Aspire-Lakewood Holdings, Inc. (NasdaqCM: ASBP)
Health Care · Pharmaceuticals · US
$8.30
-5.47% today · -97.8% 1Y
Aspire-Lakewood Holdings, Inc. (NasdaqCM: ASBP) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $11.64M and employs 2 people.
Over the last twelve months the share price has lost 97.8%, trading between 3.31 and 562.92.
Tweenvest scores Aspire-Lakewood Holdings, Inc. across four factors: quality 33/100, value 54/100. Its strongest factor is value.
ASBP price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $11.64M
- Revenue (TTM)
- $97.66K
- P/E
- —
- EPS
- -33.33
- Dividend yield
- —
- Beta (5Y)
- 0.17
- 52-week high
- $562.92
- 52-week low
- $3.31
- Avg volume (3M)
- —
- Shares outstanding
- 1.40M
- Employees
- 2
- Next earnings
- —
About Aspire-Lakewood Holdings, Inc.
Aspire Biopharma Holdings, Inc. is an emerging pharmaceutical enterprise dedicated to pioneering and commercializing innovative sublingual drug delivery systems within the United States. Its flagship product, Instaprin, is an advanced sublingual aspirin formulation known for being soluble, pH neutral, and rapidly absorbed, making it effective for both cardiovascular emergencies and general pain management. The company is diligently developing a diverse pipeline of orally dissolving formulations. This includes a melatonin-based sleep aid, essential vitamins (D, E, and K), testosterone, and semaglutide. Furthermore, Aspire Biopharma is extending its sublingual development efforts to various therapeutic areas, such as anti-nausea treatments, antipsychotic medications, erectile dysfunction drugs, and seizure control therapies, among others. They are also exploring caffeine products, including a formulation for a single-dose sublingual pre-workout supplement. Established in 2021, the firm's main operational base is situated in Estero, Florida.
- ISIN
- US7389203057
- Founded
- 2021
- Listed since
- Feb 20, 2025
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Daré Bioscience, Inc.NasdaqCM: DARE | $11.82M | $0.77 | +0.16% |
| Hepion Pharmaceuticals, Inc.OTCPK: HEPA | $11.79M | $0.12 | +48.15% |
| AcuCort AB (publ)XSAT: ACUC | $11.70M | Skr0.50 | -19.88% |
| Argenica Therapeutics LimitedASX: AGN | $11.65M | AU$0.13 | -13.33% |
| OncoZenge AB (publ)OM: ONCOZ | $11.54M | Skr4.18 | +18.92% |
| Silva Pharmaceuticals LimitedDSE: SILVAPHL | $11.53M | Tk10.40 | -16.80% |
| IDT Australia LimitedASX: IDT | $11.33M | AU$0.04 | -7.32% |
| Together Pharma LtdTASE: TGTR | $11.32M | ₪2.00 | -3.71% |
Figures last refreshed Oct 11, 2026.